[Federal Register Volume 61, Number 170 (Friday, August 30, 1996)]
[Notices]
[Page 45986]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-22219]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 25, 1996, Ciba-Geigy 
Corporation, Pharmaceuticals Division, Regulatory Compliance, 556 
Morris Avenue, Summit, New Jersey 07901, made application to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of methylphenidate (1724).
    The firm plans to manufacture finished product for distribution to 
this customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than October 29, 1996.

    Dated: August 21, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-22219 Filed 8-29-96; 8:45 am]
BILLING CODE 4410-09-M